31 research outputs found
PND19 IMPACT OF MEDICATION ADHERENCE TO DISEASE-MODIFYING DRUGS ON SEVERE RELAPSE, AND DIRECT AND INDIRECT COSTS AMONG EMPLOYEES WITH MULTIPLE SCLEROSIS
Get PDF
Diagnosis, pathophysiology and management of chronic migraine: a proposal of the Belgian Headache Society
Full text linkPMH53: IMPACT OF WEIGHT GAIN ON HEALTH-RELATED QUALITY OF LIFE (HRQL) OF BIPOLAR PATIENTS
No full textPMH44: UTILIZATION AND COST OF ATYPICAL ANTIPSYCHOTICS IN MEDICAID PATIENTS WITH DEPRESSION
No full textPND6 COMPARISON OF COSTS FOR INTERFERON BETA 1-A AND NATALIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS
Get PDFPMH18 UTILIZATION AND COST OF RESOURCES IN BIPOLAR PATIENTS RECEIVING ATYPICAL ANTIPSYCHOTICS
Get PDFPMH18 UTILIZATION AND COST OF RESOURCES IN BIPOLAR PATIENTS RECEIVING ATYPICAL ANTIPSYCHOTICS
No full textPND6 COMPARISON OF COSTS FOR INTERFERON BETA 1-A AND NATALIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS
No full textPMH21 HEALTH CARE RESOURCE UTILIZATION AND COST OF BIPOLAR I DISORDER WITH AND WITHOUT PSYCHOTIC SYMPTOMS
No full text
